ArticleClinical epigenetics2020

BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes.

Sylwia Wasiak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.